Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Eluting Balloon Angioplasty in Tunisian Population Versus Everolimus Platinum Chrome Stent

NCT05516446 is registered in ClinicalTrials.gov with General Administration of Military Health, Tunisia as lead sponsor.

NCT NCT05516446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05516446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Eluting Balloon Angioplasty in Tunisian Population Versus Everolimus Platinum Chrome Stent
Lead sponsor
General Administration of Military Health, Tunisia
Phase
Not applicable
Overall status
Unknown status
Start date
August 25, 2021
Completion date
December 31, 2022
Enrollment
290 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad), de novo stenosis, percutaneous coronary intervention (pci)